When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sitagliptin - Wikipedia

   en.wikipedia.org/wiki/Sitagliptin

   It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet XR). [8] Common side effects include headaches, swelling of the legs, and upper respiratory tract infections. [8] Serious side effects may include angioedema, low blood sugar, kidney problems, pancreatitis, and joint pain. [8]

3. Sitagliptin/metformin - Wikipedia

   en.wikipedia.org/wiki/Sitagliptin/metformin

   In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...

4. Medicare announces weight-loss drugs, including Ozempic ... - AOL

   www.aol.com/medicare-announces-15-drugs-price...

   Janumet; Janumet XR, diabetes drugs. Otezla, a psoriatic arthritis drug. ... Still, the spokesperson said, it will work with the incoming administration to "deliver meaningful solutions for patients."

5. Metformin - Wikipedia

   en.wikipedia.org/wiki/Metformin

   UK and international clinical practice guidelines do not recommend metformin as a first-line treatment [57] or do not recommend it at all, except for women with glucose intolerance. [58] The guidelines suggest clomiphene as the first medication option and emphasize lifestyle modification independently from medical treatment.

6. 2 Red Flags for Merck's Type 2 Diabetes Blockbuster - AOL

   www.aol.com/2013/05/20/2-red-flags-for-mercks...

   In the following video, Fool contributor Maxxwell Chatsko provides an update on the outlook of Merck's best-selling type 2 diabetes drug franchise of Januvia/Janumet. While the franchise reeled in ...

7. Medicare targets popular weight loss drugs Ozempic, Wegovy ...

   www.aol.com/medicare-targets-popular-weight-loss...

   Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027 ...